 SAN FRANCISCO, Feb. 21, 2020 GLOBE NEWSWIRE -- 89bio, Inc. ETNB, a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that Rohan Palekar, the companys Chief Executive Officer, will present at the SVB Leerink 9th Annual Global Healthcare Conference on Wednesday, February 26, 2020 at 11:30 AM ET in New York, NY. The live and archived webcast of the presentation will be accessible from the companys website at 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. 